Back

HFpEF: targeting SGLT2 and renal function.

27 August 2022 (08:48 - 09:06)
Organised by:
Congress Presentation Part of: HFpEF: molecular mechanisms to guide clinical management Cardiac Diseases ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

4 More presentations in this session

Presentation thumbnail
HFpEF: targeting fat metabolism.
Professor G. Schiattarella (Berlin, DE)
Slides Video
Presentation thumbnail
HFpEF: targeting aging mechanisms.
Associate Professor S. Sedej (Graz, AT)
Slides Video
Presentation thumbnail
HFpEF: targeting the vasculature.
Professor S. Heymans (Maastricht, NL)
Slides Video
Presentation thumbnail
HFpEF: molecular mechanisms to guide clinical management – discussion.
Video

Access the full session

Session thumbnail
HFpEF: molecular mechanisms to guide clinical management
Video

The Event

Event poster

ESC Congress 2022

27 August 2022 08:48 CET
You may be interested in
thumbnail
Congress Session
SGLT2 inhibitors across the spectrum of heart failure
21 May 2022
thumbnail
Congress Presentation
Optimizing foundational therapies in clinical practice. The patient with HFpEF.
23 May 2022
thumbnail
Congress Presentation
SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion.
23 May 2022
thumbnail
Congress Presentation
Panel discussion.
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources